IDO1 and colorectal carcinoma: In addition, based on the two subtypes, we identified and validated the relationship between FAM83A and IDO1 expression as a promising biomarker for predicting prognosis and distant metastasis in CRC patients in 15 independent public datasets and qRT-PCR data from 30 samples.